 medical journal says Avastin is just as effective at tackling wet age-related macular degeneration as the current treatment , Lucentis .
Drug company Novartis has been accused of trying to block trials aimed at promoting a ` cheap , safe and effective ' treatment for sight loss which would save the NHS around Â£ 102million a year .
But drug company has consistently tried to ` undermine and divert attention ' to stop trials of the cancer drug .